|
ZNF568 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33739685992396E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.14880360569236E-11 |
| Normal-vs-Stage2 |
2.21549999457338E-08 |
| Normal-vs-Stage3 |
3.81794595938345E-12 |
| Normal-vs-Stage4 |
2.34678942945266E-12 |
| Stage1-vs-Stage2 |
5.550400E-01 |
| Stage1-vs-Stage3 |
1.615360E-01 |
| Stage1-vs-Stage4 |
2.928100E-02 |
| Stage2-vs-Stage3 |
1.394370E-01 |
| Stage2-vs-Stage4 |
3.942200E-02 |
| Stage3-vs-Stage4 |
4.604600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.28146407216445E-12 |
| Normal-vs-AfricanAmerican |
2.06359999999073E-05 |
| Normal-vs-Asian |
9.857500371524E-10 |
| Caucasian-vs-AfricanAmerican |
3.374400E-01 |
| Caucasian-vs-Asian |
5.070800E-01 |
| AfricanAmerican-vs-Asian |
6.757200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.3530955789729E-11 |
| Normal-vs-Female |
1.61499702500123E-11 |
| Male-vs-Female |
9.878000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.47639694808777E-11 |
| Normal-vs-Age(41-60Yrs) |
2.84799961391968E-11 |
| Normal-vs-Age(61-80Yrs) |
1.40200073772689E-11 |
| Normal-vs-Age(81-100Yrs) |
3.624100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.413800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.671200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.585800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.133200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.465800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.537200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.824000E-04 |
| Classical-VS-Follicular |
9.959000E-01 |
| Classical-VS-Other |
5.255400E-01 |
| Classical-VS-Normal |
2.64099964120135E-10 |
| Tall-VS-Follicular |
2.997000E-03 |
| Tall-VS-Other |
5.048400E-01 |
| Tall-VS-Normal |
1.71507252844094E-12 |
| Follicular-VS-Other |
5.763200E-01 |
| Follicular-VS-Normal |
1.71879999122382E-09 |
| Other-VS-Normal |
1.739290E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.6620040333446E-11 |
| Normal-vs-N1 |
8.1601392309949E-14 |
| N0-vs-N1 |
1.470180E-02 |
|
|
